Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Midwifery Womens Health. 2008 Jul-Aug;53(4):362-75. doi: 10.1016/j.jmwh.2008.01.006.

Hormonal contraception and HIV-positive women: metabolic concerns and management strategies.

Author information

  • 1Yale University School of Nursing, 100 Church St. South, PO Box 9740, New Haven, CT 06536-0740, USA. julie.womack@yale.edu

Abstract

As HIV-positive women live longer lives, and as testing for HIV becomes more routine, clinicians can expect to see more HIV-positive women in their practices. The need to be aware of management issues particular to this population becomes increasingly important. Metabolic dysregulation is a common, long-term complication associated with HIV and is one of the most difficult to manage. Hormonal contraception also is associated with metabolic dysregulation. As more HIV-positive women choose long-term, reversible contraception, the potential for concomitant and additive side effects, and the need for careful, proactive management strategies to avoid these complications, will become more important. This article reviews research detailing the metabolic dysfunction associated with hormonal contraception and with HIV-seropositivity. It highlights reasons for concern regarding the potential, although as yet theoretical, increased risk for metabolic dysfunction when hormonal contraception is used in the presence of HIV. Suggestions for management strategies for women living with HIV who choose to use hormonal contraception are presented. These strategies should be viewed as suggestions for management until substantitive research becomes available.

PMID:
18586190
[PubMed - indexed for MEDLINE]
PMCID:
PMC2776678
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Blackwell Publishing Icon for PubMed Central
    Loading ...
    Write to the Help Desk